Clinically active IBD linked to adverse COVID-19 outcomes
(HealthDay)—Clinically active inflammatory bowel disease (IBD) is associated with adverse COVID-19 outcomes, especially in younger and middle-aged adults, according to
Read more(HealthDay)—Clinically active inflammatory bowel disease (IBD) is associated with adverse COVID-19 outcomes, especially in younger and middle-aged adults, according to
Read more(Reuters Health) – Children with Hirschsprung disease may be at increased risk for developing inflammatory bowel disease, a Canadian study
Read more